Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 20, 2009
Grant Date -
Jun 16, 2005
app pub date -
Jan 31, 2005
filing date -
May 27, 1992
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Multiple sclerosis and rheumatoid arthritis can be treated effectively using photodynamic therapy. In this protocol, a photoactive compound is administered, allowed to distribute in the effected subject, and the subject is then irradiated to activate the photoactive compound. Alternatively, the blood of a subject to be treated can be subjected to PDT extracorporeally. In the case of rheumatoid arthritis, localized treatment at the joints may also be employed.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully